Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Globe All Wellness, LLC
WARNING LETTER
•Globe All Wellness, LLC•July 8, 2011

FDA WARNING_LETTER - Globe All Wellness, LLC - July 08, 2011

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

The FDA issued a Warning Letter to Globe All Wellness, LLC, following an inspection from May 18 to July 8, 2011. The letter addresses violations concerning SlimXtreme™ Herbal Slimming Capsule and ViaXtreme™ Ultimate Sexual Enhancer Dietary Supplement for Men, marketed on www.viaxtreme.com and www.diet66.com.

Laboratory analysis confirmed SlimXtreme contained undeclared sibutramine, a withdrawn prescription drug with serious health risks. ViaXtreme contained undeclared sildenafil, sulfoaildenafil, aildenafil, and thiosildenafil, all PDE-5 inhibitors and analogues of sildenafil (Viagra's active ingredient).

These products are deemed unapproved new drugs under 21 U.S.C. § 355(a) and misbranded drugs under 21 U.S.C. §§ 352 and 353. They are excluded from dietary supplement definitions because their active pharmaceutical ingredients were authorized as new drugs or approved as new drugs before being marketed as dietary supplements or foods.

Both products are considered prescription drugs due to their potential for harmful effects and require professional supervision. They are misbranded because they lack adequate directions for lay use (21 U.S.C. § 352(f)(1)), contain false/misleading safety statements and fail to reveal material facts about risks (21 U.S.C.

Company
Globe All Wellness, LLC
Inspection Date
July 8, 2011
Product Type
Drugs
Office
Department of Health and Human Services
People
  • Emma R. Singleton (District Director)
  • Matthew B. Thomaston (Investigator)
Open in Dashboard

ID · f3868ab1-4b6d-4939-ad72-fb8ff21a920b

Violation Codes10
21.U.S.C. 355(a)21 U.S.C. 35221 U.S.C. 35321 U.S.C. 321(ff)(3)(B)(ii)21 U.S.C. 321(ff)(3)(B)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21 U.S.C. 331(d)21 U.S.C. 353(b)(1)(A)21 U.S.C. 352(f)(1)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.